Clinical Trials on MDR-TB in China

Total 75 results

The First Affiliated Hospital with Nanjing Medical...

Unknown

Study of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TB (rhIL-2)

MDR TB

China
Shanghai Pulmonary Hospital, Shanghai, China
Huashan Hospital; Shanghai Public Health Clinical Center; Anhui Chest Hospital; No.85 Hospital, Changning, Shanghai, China and other collaborators

Recruiting

A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB

MDR-TB

China
Shanghai Pulmonary Hospital, Shanghai, China
Huashan Hospital; Shanghai Public Health Clinical Center; No.85 Hospital, Changning...

Recruiting

A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB

Immunotherapy | MDR-TB

China
Sun Yat-sen University

Recruiting

A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCL

Pediatric Cancer | Anaplastic Lymphoma | MDD | MRD | Lymphoma, Nonhodgkin

China
Peking University Third Hospital
Beijing Geriatric Hospital

Recruiting

Risk Factors and Biomarkers for Post-tuberculosis Lung Damage

Pulmonary TB

China
Zhejiang Provincial Hospital of TCM

Unknown

Study on High-risk MDS Patients Based on RNA-seq Technology (MDS&RNA-seq)

MDS

China
Xuanwu Hospital, Beijing

Recruiting

A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy

Immunotherapy | ADR

China
The Second Hospital of Shandong University

Not yet recruiting

Allogenic NK Cell Transfusion Azacitidine MDS-EB

MDS-EB

China
Nanfang Hospital of Southern Medical University

Recruiting

Withdrawal or Reduction TKIs in CML-CP

MMR on 12 Month

China
Xianmin Song, MD

Recruiting

Next Generation Sequencing（NGS）Monitors Minimal Residual Disease（MRD）in Allo-PBSCT Patients

NGS Monitor MRD

China
xuna

Recruiting

A Study on the Withdrawal of Second-generation Tyrosine Kinase Inhibitors After Dose Reduction in Patients With CML

MMR on 12 Month

China
Shanghai Pulmonary Hospital, Shanghai, China
University of California, Los Angeles; Bill and Melinda Gates Foundation; Shanghai... and other collaborators

Completed

Pilot Clinical Trial of PRS TB Regimen I - Phase II

Pulmonary Tuberculosis TB in Sputum: (+) Microscopy

China
Ruijin Hospital

Recruiting

Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS (PANDA-T0)

P53 Mutation | Myeloid Malignancy | MDS | Aml

China
Peking University People's Hospital

Recruiting

Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction

Acute Leukemia | MDS | CML | MDS/MPN

China
Air Force Military Medical University, China

Completed

Effect of Cap-assisted Esophagogastroduodenoscopy on Observation of Major Duodenal Papilla

Observation of Major Duodenal Papilla (MDP)

China
Peking Union Medical College Hospital

Not yet recruiting

Hetrombopag for Low/Intermediate-1 Risk MDS With Thrombocytopenia

MDS

China
Sichuan University

Unknown

Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT

MDS | Leukemia, Acute

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML

CML, CML-CP,MMR,TKI

China
Xuanzhu Biopharmaceutical Co., Ltd.

Not yet recruiting

To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS

AML | MDS

China
The First Affiliated Hospital with Nanjing Medical...
Jiangbin Hospital Affiliated to Jiangsu University; Nanjing Second Hospital; Jiangning...

Recruiting

Clinical Study of Azacitidine Combined With Ruxolitinib in the Treatment of Higher-risk MDS/MPN

MDS/MPN

China
Fujian Medical University

Recruiting

Low-dose AZA Combined With Short Term CAG Derived Regimen as a Bridging Treatment in Patients With Advanced MDS Prior to Allo-HSCT

MDS-EB

China
Shanghai Tong Ren Hospital

Recruiting

Adaptive Treatment for Acute Myeloid Leukemia Based on D14 MRD Results (AVS)

AML | MRD

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression

Major Depressive Disorder (MDD)

China
Central South University

Unknown

Effect of Short-Term Mindfulness-Based Training For Major Depression Disorder: An Eye-Tracking Study

MDD

China
Xianmin Song, MD

Recruiting

Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies

Leukemia, Myeloid, Acute | Myeloid Malignancy | MDS | Hematopoietic Stem Cell Transplantation

China
Shanghai Mental Health Center
National Natural Science Foundation of China; Shanghai Jiao Tong University... and other collaborators

Recruiting

Electroencephalography-based Precise Repetitive Transcranial Magnetic Stimulation Treatment

Major Depressive Disorder (MDD)

China
Luye Pharma Group Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

China
Peking Union Medical College Hospital

Unknown

A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia

Low/Intermediate Risk-1 MDS

China
Sheng-Li Xue, MD
Northern Jiangsu Province People's Hospital; The Second People's Hospital of... and other collaborators

Recruiting

Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL

Hematopoietic Stem Cell Transplantation | ALL | MRD-positive

China
The First Affiliated Hospital with Nanjing Medical...

Unknown

A Clinical Trial Evaluating the Efficacy of Ultra Low Dose of Decitabine in Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes (MDS)

China
Longbio Pharma

Active, not recruiting

A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects

Myelodysplastic Syndrome (MDS)

China
Changping Laboratory

Recruiting

rTMS Therapy for Treatment-Resistant Depression With Different Targets Guided by pBFS

Major Depressive Disorder | Treatment Resistant Depression | MDD

China
Changping Laboratory

Recruiting

pBFS-Guided rTMS Therapy Over Different Targets for Treatment-Resistant Depression

Major Depressive Disorder | Treatment Resistant Depression | MDD

China
Shanghai Mental Health Center

Not yet recruiting

Effectiveness of MST Versus ECT for Major Depressive Episode

Major Depressive Disorder (MDD)

China
Institute of Hematology & Blood Diseases Hospital...
Beijing Health Alliance Charitable Foundation

Recruiting

The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes

Lower Risk MDS Per IPSS-R

China
Changping Laboratory

Recruiting

pBFS Guided rTMS Therapy Over Different Targets for Treatment-Resistant Depression

Major Depressive Disorder | Treatment Resistant Depression | MDD

China
Guangdong Association of Clinical Trials

Recruiting

Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC

MRD

China
Changping Laboratory

Recruiting

pBFS Guided VS "5-cm Rule" rTMS Over DLPFC for MDD

Major Depression | MDD

China
The First Affiliated Hospital of Soochow University

Recruiting

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

AML | MDS | Old Age; Debility | Hematologic Cancer

China
Chinese PLA General Hospital
Navy General Hospital, Beijing

Completed

Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML）

AML | MDS

China
Wave Neuroscience

Completed

Feasibility Study to Test Clinical Efficacy of Low Energy AC Magnetic Field to Treat Major Depression

Major Depressive Disorder (MDD)

United States, China
Wuhan Union Hospital, China

Recruiting

The Diagnostic Value of Hybrid PET/MR for Systemic Amyloidosis

PET/MR | Systemic Amyloidosis

China
Shenzhen People's Hospital

Enrolling by invitation

Significance of MRD After Surgery in Driver Gene-positive and Driver Gene-negative Stage IB-IIA NSCLC

NSCLC MRD ctDNA

China
Li Xiaorong
Shanghai Refreshgene Technology Co., Ltd.

Recruiting

The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR)

PDR - Proliferative Diabetic Retinopathy

China
Nanfang Hospital of Southern Medical University
Xiangya Hospital of Central South University; Peking University People's Hospital and other collaborators

Unknown

Risk-stratified Therapy Based on Molecular Cytogenetic Aberration and Treatment Response in AML

MRD | Risk-directed Therapy | Cytogenetic Abnormality | Molecular Abnormality

China
Shanghai Mental Health Center
Su Zhou YiHua Biotechnology Co. LTD

Completed

Comparison of Anyu Peibo With Placebo in Treatment of MDD

Major Depressive Disorder (MDD)

China
Ascentage Pharma Group Inc.
Suzhou Yasheng Pharmaceutical Co., Ltd.

Recruiting

A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.

Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

AML | MDS

China
West China Hospital
First Affiliated Hospital of Chongqing Medical University; Sichuan Cancer Hospital... and other collaborators

Recruiting

Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer

Rectal Cancer | Radiotherapy | Anti-PD-1 Antibody | MSI-H | Mmr Deficiency

China
Sun Yat-sen University

Recruiting

Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer

Colorectal Cancer Stage II | Colorectal Cancer Stage III | MSI-H | Mmr Deficiency

China

Clinical Trials on MDR-TB in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations